|
1
|
Wei J, Chen J, Ju P, Ma L, Chen L, Ma W, Zheng T, Yang G, Wang YX. Synthesis and Biological Evaluation of 4β-N-Acetylamino Substituted Podophyllotoxin Derivatives as Novel Anticancer Agents. Front Chem 2019; 7:253. [PMID: 31106192 PMCID: PMC6491884 DOI: 10.3389/fchem.2019.00253] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2018] [Accepted: 03/29/2019] [Indexed: 12/29/2022] Open
Abstract
A series of novel podophyllotoxin derivatives obtained by 4β-N-acetylamino substitution at C-4 position was designed, synthesized, and evaluated for in vitro cytotoxicity against four human cancer cell lines (EC-9706, HeLA, T-24 and H460) and a normal human epidermal cell line (HaCaT). The cytotoxicity test indicated that most of the derivatives displayed potent anticancer activities. In particular, compound 12h showed high activity with IC50 values ranging from 1.2 to 22.8 μM, with much better cytotoxic activity than the control drug etoposide (IC50: 8.4 to 78.2 μM). Compound 12j exhibited a promising cytotoxicity and selectivity profile against T24 and HaCaT cell lines with IC50 values of 2.7 and 49.1 μM, respectively. Compound 12g displayed potent cytotoxicity against HeLA and T24 cells with low activity against HaCaT cells. According to the results of fluorescence-activated cell sorting (FACS) analysis, 12g induced cell cycle arrest in the G2/M phase accompanied by apoptosis in T24 and HeLA cells. Furthermore, the docking studies showed possible interactions between human DNA topoisomerase IIα and 12g. These results suggest that 12g merits further optimization and development as a new podophyllotoxin-derived lead compound.
Collapse
Affiliation(s)
- Jinbao Wei
- King's Lab, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.,Department of Pharmacy, Institute of Wudang Herbal Medicine Research, Taihe Hospital, Hubei University of Medicine, Shiyan, China
| | - Jinghong Chen
- Shanghai Mental Health Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| | - Peijun Ju
- Shanghai Mental Health Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| | - Le Ma
- King's Lab, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China
| | - Li Chen
- Department of Pharmacy, Institute of Wudang Herbal Medicine Research, Taihe Hospital, Hubei University of Medicine, Shiyan, China
| | - Weidong Ma
- Department of Pharmacy, Institute of Wudang Herbal Medicine Research, Taihe Hospital, Hubei University of Medicine, Shiyan, China
| | - Tao Zheng
- Department of Pharmacy, Institute of Wudang Herbal Medicine Research, Taihe Hospital, Hubei University of Medicine, Shiyan, China
| | - Guangyi Yang
- Baoan Hospital of Traditional Chinese Medicine, Shenzhen, China
| | - Yong-Xiang Wang
- King's Lab, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China
| |
Collapse
|
|
2
|
Ren Y, Wei M, Still PC, Yuan S, Deng Y, Chen X, Himmeldirk K, Kinghorn AD, Yu J. Synthesis and Antitumor Activity of Ellagic Acid Peracetate. ACS Med Chem Lett 2012. [PMID: 23185648 DOI: 10.1021/ml300065z] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
Ellagic acid (1) was synthesized for the first time from methyl gallate through 3-pentagalloylglucose (α-PGG), and ellagic acid peracetate (3,4,3',4'-tetra-O-acetylellagic acid, 2) was derived from 1 by acetylation. Oral administration of 2 suppressed melanoma growth significantly in C7BL/6 immunocompetent mice without having any effect on natural killer (NK) cell activity. Comparison of the immunoenhancing activities of 1 and 2 indicated that the latter compound increased white blood cell quantities in peripheral blood and immune cells enriched from the bone marrow and liver of mice. Therefore, both the antitumor efficacy and the immunity enhancement by 2 were greater than those by 1. In addition, on oral administration neither 1 nor 2 resulted in whole body, liver, or spleen weight changes of normal, tumor-free mice, indicating that these compounds are potentially non-toxic to mice. It was shown that ellagic acid peracetate (2) inhibits B16 melanoma cell growth in vitro, and induces B16 cell apoptosis, corresponding to BCL-2 down-regulation. Collectively, the present data imply that 2 can suppress tumor growth by enhancing mouse immunity and inducing tumor cell apoptosis without apparent side effects.
Collapse
Affiliation(s)
- Yulin Ren
- Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, and ‡Department of
Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio 43210, United
States
- Department of Chemistry and Biochemistry, ∥Edison Biotechnology Institute, ⊥Department of
Biomedical Sciences, and
- Molecular and Cellular Biology Program, Ohio University, Athens, Ohio 45701,
United States
- Comprehensive Cancer Center, and #Division of Hematology, College of Medicine, The Ohio State University, Columbus,
Ohio 43210, United States
| | - Min Wei
- Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, and ‡Department of
Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio 43210, United
States
- Department of Chemistry and Biochemistry, ∥Edison Biotechnology Institute, ⊥Department of
Biomedical Sciences, and
- Molecular and Cellular Biology Program, Ohio University, Athens, Ohio 45701,
United States
- Comprehensive Cancer Center, and #Division of Hematology, College of Medicine, The Ohio State University, Columbus,
Ohio 43210, United States
| | - Patrick C. Still
- Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, and ‡Department of
Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio 43210, United
States
- Department of Chemistry and Biochemistry, ∥Edison Biotechnology Institute, ⊥Department of
Biomedical Sciences, and
- Molecular and Cellular Biology Program, Ohio University, Athens, Ohio 45701,
United States
- Comprehensive Cancer Center, and #Division of Hematology, College of Medicine, The Ohio State University, Columbus,
Ohio 43210, United States
| | - Shunzong Yuan
- Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, and ‡Department of
Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio 43210, United
States
- Department of Chemistry and Biochemistry, ∥Edison Biotechnology Institute, ⊥Department of
Biomedical Sciences, and
- Molecular and Cellular Biology Program, Ohio University, Athens, Ohio 45701,
United States
- Comprehensive Cancer Center, and #Division of Hematology, College of Medicine, The Ohio State University, Columbus,
Ohio 43210, United States
| | - Youcai Deng
- Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, and ‡Department of
Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio 43210, United
States
- Department of Chemistry and Biochemistry, ∥Edison Biotechnology Institute, ⊥Department of
Biomedical Sciences, and
- Molecular and Cellular Biology Program, Ohio University, Athens, Ohio 45701,
United States
- Comprehensive Cancer Center, and #Division of Hematology, College of Medicine, The Ohio State University, Columbus,
Ohio 43210, United States
| | - Xiaozhuo Chen
- Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, and ‡Department of
Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio 43210, United
States
- Department of Chemistry and Biochemistry, ∥Edison Biotechnology Institute, ⊥Department of
Biomedical Sciences, and
- Molecular and Cellular Biology Program, Ohio University, Athens, Ohio 45701,
United States
- Comprehensive Cancer Center, and #Division of Hematology, College of Medicine, The Ohio State University, Columbus,
Ohio 43210, United States
| | - Klaus Himmeldirk
- Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, and ‡Department of
Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio 43210, United
States
- Department of Chemistry and Biochemistry, ∥Edison Biotechnology Institute, ⊥Department of
Biomedical Sciences, and
- Molecular and Cellular Biology Program, Ohio University, Athens, Ohio 45701,
United States
- Comprehensive Cancer Center, and #Division of Hematology, College of Medicine, The Ohio State University, Columbus,
Ohio 43210, United States
| | - A. Douglas Kinghorn
- Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, and ‡Department of
Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio 43210, United
States
- Department of Chemistry and Biochemistry, ∥Edison Biotechnology Institute, ⊥Department of
Biomedical Sciences, and
- Molecular and Cellular Biology Program, Ohio University, Athens, Ohio 45701,
United States
- Comprehensive Cancer Center, and #Division of Hematology, College of Medicine, The Ohio State University, Columbus,
Ohio 43210, United States
| | - Jianhua Yu
- Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, and ‡Department of
Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio 43210, United
States
- Department of Chemistry and Biochemistry, ∥Edison Biotechnology Institute, ⊥Department of
Biomedical Sciences, and
- Molecular and Cellular Biology Program, Ohio University, Athens, Ohio 45701,
United States
- Comprehensive Cancer Center, and #Division of Hematology, College of Medicine, The Ohio State University, Columbus,
Ohio 43210, United States
| |
Collapse
|
|
3
|
Daniels RN, Melancon BJ, Wang EA, Crews BC, Marnett LJ, Sulikowski GA, Lindsley CW. Progress toward the Total Synthesis of Lucentamycin A: Total Synthesis and Biological Evaluation of 8-epi-Lucentamycin A. J Org Chem 2009; 74:8852-5. [DOI: 10.1021/jo902115s] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- R. Nathan Daniels
- Departments of Chemistry, Biochemistry, and Pharmacology, Vanderbilt University, Nashville, Tennessee 37232
| | - Bruce J. Melancon
- Departments of Chemistry, Biochemistry, and Pharmacology, Vanderbilt University, Nashville, Tennessee 37232
| | - Emily A. Wang
- Departments of Chemistry, Biochemistry, and Pharmacology, Vanderbilt University, Nashville, Tennessee 37232
| | - Brenda C. Crews
- Departments of Chemistry, Biochemistry, and Pharmacology, Vanderbilt University, Nashville, Tennessee 37232
| | - Lawrence J. Marnett
- Departments of Chemistry, Biochemistry, and Pharmacology, Vanderbilt University, Nashville, Tennessee 37232
| | - Gary A. Sulikowski
- Departments of Chemistry, Biochemistry, and Pharmacology, Vanderbilt University, Nashville, Tennessee 37232
| | - Craig W. Lindsley
- Departments of Chemistry, Biochemistry, and Pharmacology, Vanderbilt University, Nashville, Tennessee 37232
| |
Collapse
|